Literature DB >> 3306517

Absorption and metabolic effects of different types of estrogens and progestogens.

R A Lobo.   

Abstract

The classes of estrogens and progestogens currently in use and their routes of administration have been considered. The decision to prescribe any given estrogen or progestogen and by a particular route has a significant impact on cardiovascular risk factors. Among the estrogens, native estradiol and estrone are favored over equine and synthetic estrogens. Given this choice, oral and systemic routes of administration are not sufficiently different clinically to endorse one method over the other, except for the unusual hypertensive woman or the patient with a history of thromboembolic phenomena. Among the progestogens, oral micronized progesterone offers much promise for use in postmenopausal women. However, the oral use of lower doses of other progestogens seems appropriate at the present time. With the availability of oral micronized progesterone and in time a transdermal system, the need for alternate routes of administration for other progestogens seems unnecessary.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3306517

Source DB:  PubMed          Journal:  Obstet Gynecol Clin North Am        ISSN: 0889-8545            Impact factor:   2.844


  4 in total

Review 1.  Development of a Pediatric Fertility Preservation Program: A Report From the Pediatric Initiative Network of the Oncofertility Consortium.

Authors:  Molly B Moravek; Leslie C Appiah; Antoinette Anazodo; Karen C Burns; Veronica Gomez-Lobo; Holly R Hoefgen; Olivia Jaworek Frias; Monica M Laronda; Jennifer Levine; Lillian R Meacham; Mary Ellen Pavone; Gwendolyn P Quinn; Erin E Rowell; Andrew C Strine; Teresa K Woodruff; Leena Nahata
Journal:  J Adolesc Health       Date:  2019-01-14       Impact factor: 5.012

Review 2.  Treating menopause - MHT and beyond.

Authors:  Susan R Davis; Rodney J Baber
Journal:  Nat Rev Endocrinol       Date:  2022-05-27       Impact factor: 47.564

3.  The effect of ketoconazole and diltiazem on oestrogen metabolism in postmenopausal women after single dose oestradiol treatment.

Authors:  Anita Annas; Kjell Carlström; Gunnar Alván; Ayman AL-Shurbaji
Journal:  Br J Clin Pharmacol       Date:  2003-09       Impact factor: 4.335

Review 4.  Safety, efficacy and patient acceptability of drospirenone and estradiol in the treatment of menopausal vasomotor symptoms: a review.

Authors:  Sebastián Carranza-Lira
Journal:  Clin Interv Aging       Date:  2009-05-14       Impact factor: 4.458

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.